Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis
暂无分享,去创建一个
J. Higgins | P. Vickerman | L. Degenhardt | M. Hickman | J. Grebely | B. Hajarizadeh | S. Larney | L. Tran | Thomas Santo | C. French | C. Ferraro | Daniel E Stewart | Shally Zhou | Carla Puca | Claire F Ferraro
[1] P. Read,et al. Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: A systematic review and meta-analysis. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] Graeme Henderson,et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action , 2019, The Lancet.
[3] J. Leung,et al. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators? , 2019, The Journal of infectious diseases.
[4] Josephine G. Walker,et al. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. , 2019, The lancet. Gastroenterology & hepatology.
[5] J. E. Dorn,et al. The 2019 , 2019, International Journal of Cultural Property.
[6] S. Hutchinson,et al. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. , 2019, The lancet. HIV.
[7] Josephine G. Walker,et al. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis , 2018, The Lancet. Infectious diseases.
[8] F. Altice,et al. Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine , 2018, Journal of acquired immune deficiency syndromes.
[9] Y. Sazonova,et al. Trends in HIV prevalence among people injecting drugs, men having sex with men, and female sex workers in Ukraine , 2018, International journal of STD & AIDS.
[10] J. Havens,et al. Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment , 2018, Current HIV/AIDS Reports.
[11] M. Maglione,et al. Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes: A Systematic Review. , 2020, Rand health quarterly.
[12] F. Crawford,et al. HIV Testing and awareness of HIV status among people who inject drugs in greater Kuala Lumpur, Malaysia. , 2018, AIDS care.
[13] H. Hagan,et al. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis , 2017, Addiction.
[14] J. Leung,et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review , 2017, The Lancet. Global health.
[15] J. Leung,et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review , 2017, The Lancet. Global health.
[16] F. Altice,et al. Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic. , 2017, The International journal on drug policy.
[17] L. Barajas-Nava. Oral Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection , 2017, The Journal of the Association of Nurses in AIDS Care : JANAC.
[18] L. Degenhardt,et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies , 2017, British Medical Journal.
[19] T. Vos,et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.
[20] F. Altice,et al. Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine. , 2016, Drug and alcohol dependence.
[21] Jelle J Goeman,et al. Plea for routinely presenting prediction intervals in meta-analysis , 2016, BMJ Open.
[22] K. Looker,et al. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] M. Čivljak,et al. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys. , 2016, The International journal on drug policy.
[24] Oliver Laeyendecker,et al. Community viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative study. , 2016, The lancet. HIV.
[25] S. Torres-Rueda,et al. Illicit drug use in sexual settings (‘chemsex’) and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study , 2015, Sexually Transmitted Infections.
[26] L. Marsch,et al. Opioid Use Trajectories, Injection Drug Use, and Hepatitis C Virus Risk Among Young Adult Immigrants from the Former Soviet Union Living in New York City , 2015, Journal of addictive diseases.
[27] E. Poveda,et al. The START Trial: Definitive Evidence to Treat All HIV-Positive Persons Regardless of CD4 Counts. , 2015, AIDS reviews.
[28] C. Celum,et al. Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions , 2015, Journal of acquired immune deficiency syndromes.
[29] J. Parry,et al. Sex work amongst people who inject drugs in England, Wales and Northern Ireland: findings from a National Survey of Health Harms and Behaviours. , 2015, The International journal on drug policy.
[30] A. Nardone,et al. WHO ‘Treatment as Prevention’ guidelines are unlikely to decrease HIV transmission in the UK unless undiagnosed HIV infections are reduced , 2014, AIDS.
[31] P. Vickerman,et al. Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] Chyvette T. Williams,et al. Racial Disparities in HIV Prevalence and Risk Behaviors Among Injection Drug Users and Members of Their Risk Networks , 2013, Journal of acquired immune deficiency syndromes.
[33] P. Vickerman,et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[34] Sarah J. Erickson,et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. , 2012, American journal of public health.
[35] J. Bryant,et al. Syringe Coverage in an Australian Setting: Does a High Level of Syringe Coverage Moderate Syringe Sharing Behaviour? , 2012, AIDS and Behavior.
[36] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[37] T. Rhodes,et al. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed , 2010, The Lancet.
[38] Matthew Hickman,et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage , 2010, The Lancet.
[39] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[40] Evan Wood,et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study , 2009, BMJ : British Medical Journal.
[41] J. Parry,et al. Improvingblood‐borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service , 2009, Journal of viral hepatitis.
[42] David J Spiegelhalter,et al. A re-evaluation of random-effects meta-analysis , 2009, Journal of the Royal Statistical Society. Series A,.